27 research outputs found
TGF-β-Mediated Sustained ERK1/2 Activity Promotes the Inhibition of Intracellular Growth of Mycobacterium avium in Epithelioid Cells Surrogates
Transforming growth factor beta (TGF-β) has been implicated in the pathogenesis of several diseases including infection with intracellular pathogens such as the Mycobacterium avium complex. Infection of macrophages with M. avium induces TGF-β production and neutralization of this cytokine has been associated with decreased intracellular bacterial growth. We have previously demonstrated that epithelioid cell surrogates (ECs) derived from primary murine peritoneal macrophages through a process of differentiation induced by IL-4 overlap several features of epithelioid cells found in granulomas. In contrast to undifferentiated macrophages, ECs produce larger amounts of TGF-β and inhibit the intracellular growth of M. avium. Here we asked whether the levels of TGF-β produced by ECs are sufficient to induce a self-sustaining autocrine TGF-β signaling controlling mycobacterial replication in infected-cells. We showed that while exogenous addition of increased concentration of TGF-β to infected-macrophages counteracted M. avium replication, pharmacological blockage of TGF-β receptor kinase activity with SB-431542 augmented bacterial load in infected-ECs. Moreover, the levels of TGF-β produced by ECs correlated with high and sustained levels of ERK1/2 activity. Inhibition of ERK1/2 activity with U0126 increased M. avium replication in infected-cells, suggesting that modulation of intracellular bacterial growth is dependent on the activation of ERK1/2. Interestingly, blockage of TGF-β receptor kinase activity with SB-431542 in infected-ECs inhibited ERK1/2 activity, enhanced intracellular M. avium burden and these effects were followed by a severe decrease in TGF-β production. In summary, our findings indicate that the amplitude of TGF-β signaling coordinates the strength and duration of ERK1/2 activity that is determinant for the control of intracellular mycobacterial growth
Motor function and perception in children with neuropsychiatric and conduct problems: results from a population based twin study
Nitrogen in interstitial waters in the Sahel : natural baseline, pollutant or resource?
Nitrate in the unsaturated zone between the soil surface and the water table was studied in agroforestry Parklands in north western Senegal by examination of samples obtained by hand auger. Depending on location, water tables existed at depths between 10 and 35m below ground. Previous studies of groundwater in this region had found that large concentrations of nitrate were unconnected with anthropogenic activity. The objective of this study was to determine whether nitrogen fixing vegetation had a role in groundwater nitrate accumulation and whether roots of trees were located deeply enough to access the nitrate. Accordingly, sample profiles were augered close to stems of nitrogen fixing trees, non-nitrogen fixing trees and also in adjacent areas that were unaffected by tree presence. These adjacent areas were typically open pasture or cultivated fields. Tree fine roots were quantified in the samples and examined for the presence of mycorrhizas. Similarly, sand/soil samples were examined and tested for the presence of nitrogen fixing rhizobia that were capable of forming functional nodules on appropriate host plants. Concentrations of nitrate were greatest in soils beneath nitrogen fixing trees and nitrate was more plentiful in profiles augered beneath nitrogen fixing crops than it was elsewhere suggesting that N-fixation was the source of the nitrate. The concentrrations of nitrate that were found in the unsaturated zone were greatly in excess of the WHO recommended limit for nitrate in drinking water. High NO3-N/Cl ratios confirm insitu production of nitrate, and indicate that this is a natural baseline occurrence related to N-fixation. The nitrate is moving down the profile and impacts the groundwater unless it can be intercepted by plant roots. NO3-N amounts in solution in the soil profile varied between 75 and 1000kg ha–1 beneath trees and between 120 and 400kg ha–1 in areas outwith tree crowns. Although these quantities of N occupy the lower end of the range of N values obtained in north American deserts, they comprise a considerable dryland resource where amounts of organic fertilizer are limited and where cost prohibits the use of commercial fertilizers. Roots of both nitrogen fixing and non-nitrogen fixing trees were deep enough to access the nitrate but the small amounts of available water at intermediate depths suggest that large scale uptake of nitrate will only be possible in the wetter zones located close to the water table. Shallow roots tended to be more heavily colonized by mycorrhizas than deeper roots but mycorrhizas were recovered from roots located 22m below ground. Tree roots and rhizobia had similar patterns of distribution. They were commonest close to the soil surface, less frequent at intermediate depths and tended to increase in frequency close to the water table
In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancer
In solid tumors, resistance to therapy inevitably develops upon treatment with cytotoxic drugs or molecularly targeted therapies. Here, we describe a system that enables pooled shRNA screening directly in mouse hepatocellular carcinomas (HCC) in vivo to identify genes likely to be involved in therapy resistance. Using a focused shRNA library targeting genes located within focal genomic amplifications of human HCC, we screened for genes whose inhibition increased the therapeutic efficacy of the multikinase inhibitor sorafenib. Both shRNA-mediated and pharmacological silencing of Mapk14 (p38alpha) were found to sensitize mouse HCC to sorafenib therapy and prolong survival by abrogating Mapk14-dependent activation of Mek-Erk and Atf2 signaling. Elevated Mapk14-Atf2 signaling predicted poor response to sorafenib therapy in human HCC, and sorafenib resistance of p-Mapk14-expressing HCC cells could be reverted by silencing Mapk14. Our results suggest that a combination of sorafenib and Mapk14 blockade is a promising approach to overcoming therapy resistance of human HCC